CEB-01 by Cebiotex for Leiomyosarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Leiomyosarcoma.

Inflammatory bowel disease associated with slightly increased risk of heart failure

Inflammatory bowel disease (IBD) is associated with a slightly increased risk of heart failure up to 20 years after diagnosis, according to a comprehensive registry

May 22, 2024

Poor sleep before surgery linked to increased risk of postoperative delirium

People who experience poor sleep in the month before surgery may be more likely to develop postoperative delirium, according to new research being presented at

October 21, 2024

Rep. Dan Crenshaw With Urgent Call For Support At House Rules Committee On Psychedelics

In a recent congressional hearing, Rep. Dan Crenshaw again pleaded his case for the advancement of psychedelic use in the mentally ill. The matter at

July 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.